Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 7
Submit an article Journal homepage
54
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Combination of 13-cis Retinoic Acid and Interferon-α in the Treatment of Recurrent or Refractory Peripheral T-cell Lymphoma

Chin-Lun Huang Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
,
Zhong-Zhe Lin Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
,
Ih-Jen Su Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan
,
Tsu-Yi Chao Tri-Service General Hospital, Taipei, Taiwan
,
Hwei-Fang Tien Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
,
Ming-Chih Chang Mackay Memorial Hospital, Taipei, Taiwan
,
Ming-Che Huang Jen-Ai Municipal Hospital, Taipei, Taiwan
,
Woei-Yau Kao Tri-Service General Hospital, Taipei, Taiwan
,
Jih-Luh Tang Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
,
Kun-Heui Yeh Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
,
Chiu-Hwa Wang Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
,
Chih-Hung Hsu Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
,
Mei-Yin Liu Cancer Research Center, National Taiwan University College of Medicine, Taipei, Taiwan
&
Ann-Lii Cheng Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
 show all
Pages 1415-1420 | Published online: 01 Jul 2009

  • Cheng, A.L., Chen, Y.C. and Su, I.J. (1989) "Adult non-Hodgkin's lymphoma in Taiwan area: A clinicopathologic study of 123 cases based on Working Formulation classification", Journal of the Formosa Medical Association 88, 108 - 113
  • Su, I.J., Wang, C.H. and Cheng, A.L. (1988) "Characterization of the spectrum of postthymic T-cell malignancies in Taiwan: a clinicopathologic study of HTLV-1-positive and HTLV-1-negative cases", Cancer 61, 2060 - 2070
  • Su, I.J., Shih, L.Y., Kadin, M.E., Dun, P. and Hsu, S.M. (1985) "Pathologic and immunologic characterization of malignant lymphoma in Taiwan: with special reference to retrovirus-associated adult T-cell lymphoma/leukemia", American Journal of Clinical Pathology 84, 715 - 723
  • Cheng, A.L., Cheng, Y.C., Wang, C.H., Su, I.J., Hsieh, H.C., Chang, J.Y., Hwang, W.S., Su, W.C., Liu, T.W. and Tien, H.F. (1989) "Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades--Should peripheral T-cell lymphoma be considered separately?", Journal of Clinical Oncology 7, 725 - 731
  • Su, I.J., Hsieh, H.C., Lin, K.H., Uen, W.C., Kao, C.L., Chen, C.J., Cheng, A.L., Kadin, M.E. and Chen, J.Y. (1991) "Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis", Blood 77, 799 - 808
  • Armitage, J.O. and Weisenburger, D.D. (1998) "New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes", Journal of Clinical Oncology 16, 2780 - 2795
  • López-Guillermo, A., Cid, J., Salar, A., López, A., Montalban, C., Castrillo, J.M., Gonzalez, M., Ribera, J.M., Brunet, S., Garcia-Conde, J., Fernandez de Sevilla, A., Bosch, F. and Montserrat, E. (1998) "Peripheral T-cell lymphomas: initial feature, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification", Annals of Oncology 9, 849 - 855
  • Harris, N., Jaffe, E., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., DeWolf-Peeters, C., Falini, B. and Gatter, A.C. (1994) "A revised European-American Classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood 84, 1361 - 1392
  • Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. and Bloomfield, C.D. (1999) "World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical Advisory Committee meeting-Airlie House, Virginia, November 1997", Journal of Clinical Oncology 17, 3835 - 3849
  • Cheng, A.L. and Su, I.J. (1991) "Peripheral T-cell lymphoma and adult T-cell lymphoma/leukemia", In: Carbone, P.P., eds, Current Therapy in Hematology/Oncology (Decker, Philadelphia, BC), pp 360 - 364
  • Cheng, A.L., Su, I.J., Chen, Y.C., Uen, W.C. and Wang, C.H. (1993) "Characteristic clinicopathologic features of Epstein-Barr-virus associated peripheral T-cell lymphoma", Cancer 72, 909 - 916
  • Su, I.J. and Cheng, A.L. (1991) "Expression of growth-related genes and drug-resistance genes in HTLV-1-positive and HTLV-1-negative postthymic T-cell malignancies", Annals of Oncology 2 (Suppl 2), 151 - 155
  • Cheng, A.L., Su, I.J., Chen, Y.C., Lee, T.C. and Wang, C.H. (1993) "Expression of P-glycoprotein and glutathione-S-transferase in recurrent lymphomas: the possible role of Epstein-Barr virus, immunophenotypes, and other predisposing factors", Journal of Clinical Oncology 11, 109 - 115
  • Chou, J.M., Cheng, A.L., Su, I.J. and Wang, C.H. (1991) "13-cis-retinoic acid induced cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphomas", Cancer 67, 2490 - 2494
  • Cheng, A.L., Su, I.J., Chen, C.C., Tien, H.F., Lay, J.D., Chen, B.R., Pu, Y.S., Hong, R.L., Shen, M.C. and Wang, C.H. (1994) "Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study", Journal of Clinical Oncology 12, 1185 - 1192
  • Wilson, W.H., Kingma, D.W. and Wittes, R. (1994) "Lymphomatoid granulomatosis (LYG) is an EBV-positive B-cell lymphoproliferative disorder responsive to α-interferon", Proceedings of American Society of Clinical Oncology 13, 381, Abstract
  • Lindner, D.J., Borden, E.C. and Kalvakolanu, D.V. (1997) "Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo", Clinical Cancer Research 3, 931 - 937
  • Lotan, R., Clifford, J.L. and Lippman, S.M. (2000) "Retinoids and interferons: combination studies in human cancer", In: Livrea, M.A., eds, Vitamin A and Retinoids: An Update of Biological Aspects and Clinical Applications (Birkhäuser, Basel), pp 221 - 230
  • Thestrup-Pederson, K., Hammer, R., Kaltoft, K., Sogaard, H. and Zachariae, H. (1988) "Treatment of mycosis fungoides with recombinant interferon-α2a alone and in combination with etretinate", British Journal of Dermatology 118, 811 - 818
  • Lippman, S.M., Kavanagh, J.J., Paredes-Espinoza, M., Delgadillo-Madrueno, F., Paredes-Cascillas, P., Hong, W.K., Holdener, E. and Krakoff, I.H. (1992) "13-cis-retinoic-acid plus interferon α-2a: Highly active systemic therapy for squamous cell carcinoma of the cervix", Journal of the National Cancer Institute 84, 241 - 245
  • Lippman, S.M., Kavanagh, J.J., Paredes-Espinoza, M., Delgadillo-Madrueno, F., Paredes-Casillas, P., Hong, W.K., Massimini, G., Holdener, E.E. and Krakoff, I.H. (1993) "13-cis-retinoic-acid plus interferon α-2a in locally advanced squamous cell carcinoma of the cervix", Journal of the National Cancer Institute 85, 499 - 500
  • Lippman, S.M., Parkinson, D.R., Itri, L.M., Weber, R.S., Schantz, S.P., Ota, D.M., Schusterman, M.A., Krakoff, I.H., Gutterman, J.U. and Hong, W.K. (1992) "13-cis-retinoic-acid and interferon α-2a: effective combination therapy for advanced squamous cell carcinoma of the skin", Journal of the National Cancer Institute 84, 235 - 241
  • Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T. and Carbone, P.P. (1982) "Toxicity and response criteria of the Eastern Cooperative Oncology Group", American Journal of Clinical Oncology 5, 649 - 655
  • Kaplan, E.L. and Meier, P. (1958) "Nonparametric estimation from incomplete observation", Journal of the American Statistical Association 53, 457 - 481
  • Chou, W.C., Su, I.J., Tien, H.F., Liang, D.C., Wang, C.H., Chang, Y.C. and Cheng, A.L. (1996) "Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese patients with Ki-1 anaplastic large cell lymphoma-special emphasis on the tumor response to 13-cis retinoic acid", Cancer 78, 1805 - 1812
  • Cheng, A.L., Chuang, S.E. and Su, I.J. (1997) "Factors associated with the therapeutic efficacy of retinoic acids on malignant lymphomas", Journal of the Formosa Medical Association 96, 525 - 534
  • Wang, K.C., Cheng, A.L., Chuang, S.E., Hsu, H.C. and Su, I.J. (2000) "Retinoic acid-induced apoptotic pathway in T-cell lymphoma: identification of four groups of genes with differential biological functions", Experimental Hematology 28, 1441 - 1450
  • Wiegand, U.W. and Chou, R.C. (1998) "Pharmacokinetics of oral isotretinoin", Journal of the American Academy of Dermatology 39 (Suppl), S8 - S12
  • Orfanos, C.E. and Zouboulis, C.C. (1998) "Oral retinoids in the treatment of seborrhoea and acne", Dermatology 196, 140 - 147
  • Saitoh, A., Kawanabe, T., Weidong, H., Kayagaki, N., Kawamura, T., Yagita, H., Okumura, K. and Shimada, S. (2000) "Selective upregulation of fibroblast Fas ligand expression, and prolongation of Fas/Fas ligand-mediated skin allograft survival, by retinoic acid: the skin as a rationed-inducible immune privilege site", Journal of Investigative Dermatology 115, 154 - 161
  • Egle, A., Villunger, A., Kos, M., Bock, G., Gruber, J., Auer, B. and Greil, R. (1996) "Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2", European Journal of Immunology 26, 3119 - 3126
  • Marrack, P., Kappler, J. and Mitchell, T. (1999) "Type I interferons keep activated T cells alive", Journal of Experimental Medicine 189, 521 - 530
  • Yang, C.H., Murti, A., Pfeffer, S.R., Kim, J.G., Donner, D.B. and Pfeffer, L.M. (2001) "Interferon α/β.promote cell survival by activating nuclear factor κB through phosphatidylinositol 3-kinase and Akt", Journal of Biological Chemistry 276, 13756 - 13761
  • Weiss, G.R., Liu, P.Y., Alberts, D.S., Peng, Y.M., Fischer, E., Xu, M.J., Scudder, S.A., Baker, Jr., L.H., Moore, D.F. and Lippman, S.M. (1998) "13-cis-retinoic acid or all-trans-retinoic acid plus interferon-α in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial", Gynecologic Oncology 71, 386 - 390
  • Hallum, III, A.V., Alberts, D.S., Lippman, S.M., Inclan, L., Shamdas, G.J., Childers, J.M., Surwit, E.A., Modiano, M. and Hatch, K.D. (1995) "Phase II study of 13-cis-retinoic acid plus interferon-α2a in heavily pretreated squamous carcinoma of the cervix", Gynecologic Oncology 56, 382 - 386

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.